CD40LG and neoplasm: However, the synergistic effect of rMVA-CD40L and anti-TRP-1 TAA-specific mAb was lost in IL15rα−/− tumor-bearing mice (Fig. 6c, d), in contrast to the effects observed in WT counterparts treated with the combination.